ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

March 2, 2001

Fund Squeeze Results In Percentage reductions for Renewed Program Project, Center Core Grants

April 8, 1977

“Inoperable” Prostate Cancer May Be Operable, Curable

April 29, 2005

Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened

September 26, 1980

More DCT Concepts Approved By Advisors

July 10, 1992